Mutational status of the p53 gene modulates the basal level of jun N- terminal kinase and its inducibility by ultraviolet irradiation in A1-5 rat fibroblasts

Molecular Carcinogenesis

Volumn 25, Issue 4, 1999, Pages 262-272

  Ramaswamy, Nadja T ^a   Pelling, Jill C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

c jun N terminal kinase 1; p53; Ultraviolet B; Ultraviolet C

Indexed keywords

PROTEIN P21; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FIBROBLAST; GENE INDUCTION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; ULTRAVIOLET IRRADIATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INDUCTION; FIBROBLASTS; GENES, P53; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KERATINOCYTES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; RATS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0032811911     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199908)25:4<262::AID-MC5>3.0.CO;2-U     Document Type: Article

References (27)

1. Herrlich P, Ponta H, Rahmsdorf HJ. DNA damage-induced gene expression: Signal transduction and relation to growth factor signaling. Rev Physiol Biochem Pharmacol 1992;119:187-223.
2. Derijard B, Hibi M, Wu IH, et al. JNK1: A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 1994;76:1025-1037.
3. Canman CE, Kastan MB. Signal transduction. Three paths to stress relief. Nature 1996;384:213-214.
4. Liu Z-G, Baskaran R, Lea-Chou ET, et al. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 1996;384:273-275.
5. Raitano AB, Halpern JR, Hambuch TM, Sawyers CL. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci USA 1995;92:11746-11750.
6. Kharbanda S, Ren R, Pandey P, et al. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995;376:785-788.
7. Oren M, Prives C. p53: Upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996). Biochim Biophys Acta 1996;1288:R13-R19.
8. Davis RJ. MAPKs: New JNK expands the group. Trends Biochem Sci 1994;19:470-473.
9. Adler V, Fuchs SY, Kim J, et al. jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ 1995;6:1437-1446.
10. Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995;267:389-393.
11. Adler V, Pincus MR, Minamoto T, et al. Conformation-dependent phosphorylation of p53. Proc Natl Acad Sci USA 1997;94:1686-1691.
12. Canman CE, Wolff AC, Chen CY, Fornace AJ Jr, Kastan MB. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res 1994;54:5054-5058.
13. Liu M, Pelling JC. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 1995;10:1955-1960.
14. Rathmell WK, Kaufmann WK, Hurt JC, Byrd LL, Chu G. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Cancer Res 1997;57:68-74.
15. Lane DP. p53, guardian of the genome. Nature 1992; 358:15-16.
16. Milne DM, Campbell LE, Campbell DG, Meek DW. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase. JNK1. J Biol Chem 1995;270:5511-5518.
17. Hu MC, Qiu WR, Wang YP. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases. Oncogene 1997;15: 2277-2287.
18. Martinez J, Georgoff I, Martinez J, Levine AJ. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 1991;5:151-159.
19. Shim J, Lee H, Park J, Kim H, Choi EJ. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 1996;381:804-806.
20. Hennings H, Michael D, Lichti U, Yuspa SH. Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium. J Invest Dermatol 1987; 88:60-65.
21. Strickland JE, Greenhalgh DA, Koceva-Chyla A, et al. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 1988; 48:165-169.
22. Betz NA, Pelling JC. Ha-ras p21-GTP levels remain constant during primary keratinocyte differentiation. Mol Carcinog 1995;12:66-76.
23. Diaz-Guerra M, Haddow S, Baulauz C, et al. Expression of simple epithelial cytokeratins in mouse epidermal Keratinocytes harboring Harvey ras gene mutations. Cancer Res. 1992;52:680-687.
24. Fusenig NE, Amer SM, Boukamp P, Worst PK. Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull Cancer 1978;65:271-279.
25. Ramaswamy NT, Ronai Z, Pelling JC. Rapid activation of JNK1 in UV-B irradiated epidermal keratinocytes. Oncogene 1998;16:1501-1505.
26. Dhanwada KR, Dickens M, Neades R, Davis R, Pelling JC. Differential effects of UV-B and UV-C components of solar radiation on MAP kinase signal transduction pathways in epidermal keratinocytes. Oncogene 1995;11:1947-1953.
27. Adler V, Polotskaya A, Kim J, et al. Dose rate and mode of exposure are key factors in JNK activation by UV irradiation. Carcinogenesis 1996;17:2073-2076.